{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T10:43:04Z","timestamp":1772966584109,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.healun.2003.12.014","type":"journal-article","created":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T07:45:44Z","timestamp":1109663144000},"page":"296-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection"],"prefix":"10.1016","volume":"24","author":[{"given":"J\u00f8rn","family":"Carlsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren","family":"Boesgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Arendrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Aldershvilet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svend Aage","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2003.12.014_BIB1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0041-1345(00)00963-5","article-title":"Immunosuppression induction with rabbit antithymocyte globulin in heart transplantation patients","volume":"32","author":"Lavee","year":"2000","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.12.014_BIB2","first-page":"315","article-title":"Antilymphocyte antibodies in the treatment of allograft rejection","volume":"12","author":"Norman","year":"1992","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.healun.2003.12.014_BIB3","first-page":"1811","article-title":"Immunosuppression with or without ATG in heart transplantation","volume":"26","author":"Berglin","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.12.014_BIB4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1053-2498(99)00100-X","article-title":"A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation","volume":"18","author":"Carrier","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB5","first-page":"2499","article-title":"Comparison of a monoclonal anti-T cell antibody vs. ATG as prophylaxis after heart transplantation","volume":"21","author":"Wollenek","year":"1989","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.12.014_BIB6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood.V95.1.83","article-title":"Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease","volume":"95","author":"Przepiorka","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.healun.2003.12.014_BIB7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0966-3274(00)00021-6","article-title":"Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events","volume":"8","author":"Goebel","year":"2000","journal-title":"Transplant Immunol"},{"key":"10.1016\/j.healun.2003.12.014_BIB8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00007890-199802150-00020","article-title":"Blockade of the interleukin (IL)-2\/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans","volume":"65","author":"van Gelder","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2003.12.014_BIB9","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/S0041-1345(99)00308-5","article-title":"Current use of polyclonal antilymphocyte antibody preparations","volume":"31","author":"Merion","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.12.014_BIB10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2003.12.014_BIB11","first-page":"587","article-title":"A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection","volume":"9","author":"Billingham","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/00365549409011791","article-title":"Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy. Copenhagen Heart Transplant Group","volume":"26","author":"Krogsgaard","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.healun.2003.12.014_BIB13","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S1053-2498(01)00356-4","article-title":"Induction therapy in lung transplantation","volume":"20","author":"Brock","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB14","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2165\/00063030-200115110-00005","article-title":"Daclizumab","volume":"15","author":"Carswell","year":"2001","journal-title":"BioDrugs"},{"issue":"suppl","key":"10.1016\/j.healun.2003.12.014_BIB15","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1016\/S0041-1345(97)80002-4","article-title":"Seven-year experience with rabbit antithymocyte globulin after cardiac transplantation at the Montreal Heart Institute","volume":"29","author":"Beaufigeau","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2003.12.014_BIB16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1011414307636","article-title":"The challenge of rejection and cardiac allograft vasculopathy","volume":"6","author":"Cotts","year":"2001","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.healun.2003.12.014_BIB17","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","article-title":"Cellular rejection and rate of progression of transplant vasculopathy","volume":"20","author":"Jimenez","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB18","first-page":"743","article-title":"The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy","volume":"16","author":"Mehra","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB19","first-page":"452","article-title":"Repetitive nontreated episodes of grade 1B or 2 acute rejection impair long-term cardiac graft function","volume":"14","author":"Anguita","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2003.12.014_BIB20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00001573-200103000-00006","article-title":"Pathologic markers of allograft arteriopathy","volume":"16","author":"Labarrere","year":"2001","journal-title":"Curr Opin Cardiol"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249804000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:10:53Z","timestamp":1760947853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249804000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S1053249804000889"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2003.12.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction therapy after cardiac transplantation: A comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2003.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}